Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters on Advanced Pancreatic Cancer

NCT04002479 is registered in ClinicalTrials.gov with Alpha Tau Medical LTD. as lead sponsor.

NCT NCT04002479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04002479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters on Advanced Pancreatic Cancer
Lead sponsor
Alpha Tau Medical LTD.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 20, 2020
Completion date
October 31, 2026
Enrollment
37 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic pancreatic cancer, pancreatic adenocarcinoma, pancreatic cancer, unresectable pancreatic cancer